These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2917722)

  • 1. [Modern gastritis therapy. New pathogenetic concepts. Significance of Campylobacter pylori. Use of bismuth compounds. Report of the 16th meeting of the Bayern Society of Gastroenterology. Bad Dürkheim, 21-22 October 1988].
    Fortschr Med Suppl; 1989; 55():1-15. PubMed ID: 2917722
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of Campylobacter pylori-associated gastritis].
    Bielefeldt K
    Dtsch Med Wochenschr; 1988 Sep; 113(38):1495-6. PubMed ID: 3168772
    [No Abstract]   [Full Text] [Related]  

  • 3. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

  • 5. [Campylobacter pylori associated gastritis].
    Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 8. Helicobacter pylori and bismuth subnitrate.
    Sodeman WA
    Am J Gastroenterol; 1990 Sep; 85(9):1200-1. PubMed ID: 2389738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of Campylobacter pylori infection].
    Börsch G
    Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bismuth--an environmental pollutant of the future].
    Mueller RL
    Zentralbl Hyg Umweltmed; 1989 Nov; 189(2):117-24. PubMed ID: 2604843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antibacterial treatment of Campylobacter pylori-associated gastritis in children.
    De Giacomo C; Maggiore G; Licardi G; Scotta MS; Fiocca R
    Gastroenterology; 1988 Dec; 95(6):1699. PubMed ID: 3181694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Campylobacter pyloridis: a new pathogenetic hypothesis and new guidelines in the therapy of gastritis and peptic ulcer].
    D'Amore V; Prandi GC
    Minerva Dietol Gastroenterol; 1988; 34(1):13-9. PubMed ID: 3290723
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of Campylobacter-associated gastritis.
    McNulty CA
    Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ulcer--campylobacter pylori--bismuth therapy].
    Internist (Berl); 1989 Feb; 30(2 Suppl [ULKUS]):1-11. PubMed ID: 2635701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Campylobacter pylori,a commensal, opportunistic or primary pathogenic bacterium. An international discussion by experts on the occasion of the 42d meeting of the German Society for Digestive and Metabolic Diseases. Salzburg, 9-12 September 1987. Proceedings].
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():1-46. PubMed ID: 3687148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Competitive activity of a bacterial preparation on colonization and pathogenicity of C. pylori. A clinical study].
    Gismondo MR; Lo Bue AM; Chisari G; Pecorella G; Malandrino G; Petralito E
    Clin Ter; 1990 Jul; 134(1):41-6. PubMed ID: 2147608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.